Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients.
Jia B, Dong Z, Wu D, Zhao J, Wu M, An T, Wang Y, Zhuo M, Li J, Wang Y, Zhang J, Zhao X, Li S, Li J, Ma M, Chen C, Yang X, Zhong J, Chen H, Wang J, Chi Y, Zhai X, Cui S, Zhang R, Ma Q, Fang J, Wang Z.
Jia B, et al. Among authors: wang j, wang z, wang y.
Cancer Cell Int. 2020 Dec 9;20(1):590. doi: 10.1186/s12935-020-01662-5.
Cancer Cell Int. 2020.
PMID: 33298069
Free PMC article.